Transplantation Impact Factor 2024. 2022 2023 0.54 0.56 0.58 0.6. Transplantation proceedings publishes several different categories of manuscripts, all of which undergo extensive peer review by recognized authorities in the field prior to their acceptance for publication.
Net income for the first quarter of 2024 was $12.2 million, 12.6% of revenue, compared to a net loss of $2.6 million in the first quarter of 2023. Cell transplantation is an international forum dedicated to cell transplantation research and its applications,.
Revision Received 17 January 2024.
10.3389/fimmu.2024.1384823 homozygosity in any hla locus is a risk factor for specific antibody production:
Transplantation Has Been The Trusted Source For Extensive And Timely Coverage Of The Most Important Advances In Transplantation.
Discover the latest ranking, metrics and journal information for clinical transplantation.
Article Publishing Charge For Open Access.
Images References :
Finding Strategies To Combat Involuntary Loss Of Muscle.
The editors and editorial board.
Transplantation Proceedings Publishes Several Different Categories Of Manuscripts, All Of Which Undergo Extensive Peer Review By Recognized Authorities In The Field Prior To Their Acceptance For Publication.
Transplantation proceedings impact factor 2024.
Transplantation Proceedings Addresses Concerns In Transplantation Which Are Intertwined With Other Disciplines, Such As Urology, Immunosuppression, Pathology, Kidney And.
